Peter Takáč, Pharm.D., PhD

Last update: 23. 10. 2023

I. BASIC INFORMATION
I.1 Surname Takáč
I.2 Name Peter
I.3 Titles Pharm.D., PhD
I.4 Year of birth 1991
I.5 Name of the workplace University of Veterinary Medicine and Pharmacy in Košice, Department of Pharmacology and Toxicology
I.6 Address of the workplace Komenského 73, 041 81 Košice, Slovak Republic
I.7 Position lecturer
I.8 E-mail address peter.takac@uvlf.sk
I.9 Hyperlink to the entry of a person in the Register of university staff https://www.portalvs.sk/regzam/detail/27235
I.10 Name of the study field in which a person works at the university pharmacy
I.11 ORCID iD 3 https://orcid.org/0000-0001-9172-2102
3 Optional item.

II. HIGHER EDUCATION AND FURTHER QUALIFICATION GROWTH
II.a Name of the university or institution II.b Year II.c Study field and programme
II.1 First degree of higher education
II.2 Second degree of higher education University of Veterinary Medicine and Pharmacy in Košice 2015 pharmacy
II.3 Third degree of higher education Pavol Jozef Šafárik University in Košice, Faculty of Medicine 2019 medical pharmacology
II.4 Associate professor
II.5 Professor
II.6 Doctor of Science (DrSc.)

III. CURRENT AND PREVIOUS EMPLOYMENT
III.a Occupation-position III.b Institution III.c Duration
Head of the Institue of human and Clinical Pharmacology University of Veterinary Medicine and Pharmacy in Košice 2019 2020
lecturer University of Veterinary Medicine and Pharmacy in Košice 2018 2022

IV. DEVELOPMENT OF PEDAGOGICAL, PROFESSIONAL, LANGUAGE, DIGITAL AND OTHER SKILLS
IV.a Activity description, course name, other IV.b Name of the institution IV.c Year
rigorous examination procedure in the field of Pharmacy University of Veterinary Medicine and Pharmacy in Košice 2018

V. OVERVIEW OF ACTIVITIES WITHIN THE TEACHING CAREER AT THE UNIVERSITY
V.1. Overview of the profile courses taught in the current academic year according to study programmes
V.1.a Name of the profile course V.1.b Study programme V.1.c Degree V.1.d Field of study
Clinical pharmacology and pharmacotherapypharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy
Pharmacologypharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy

V.2. Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year 4
V.2.a Study programme V.2.b Degree V.2.d Field of study
4 According to Art. 6 para. 4 of the Standards for the Study Programme.

V.3. Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a Name of the field of habilitation procedure and inaugural procedure V.3.b Study field to which it is assigned

V.4. Overview of supervised final theses
V.4.a Bachelor's (first degree) V.4.b Diploma (second degree) V.4.c Dissertation (third degree)
V.4.1 Number of currently supervised theses 0 4 0
V.4.2 Number of defended theses 0 17 0

V.5. Overview of other courses taught in the current academic year according to study programmes
V.5.a Name of the course V.5.b Study programme V.5.c Degree V.5.d Field of study
Pharmacologypharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy
Phytopharmaceuticalspharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy
Medicines applied during pregnancy and lactationpharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy

VI. OVERVIEW OF THE RESEARCH/ARTISTIC/OTHER OUTPUTS
VI.1. Overview of the research/artistic/other outputs and the corresponding citations
VI.1.a Overall VI.1.b Over the last six years
VI.1.1 Number of the research/artictic/other outputs 41 38
VI.1.2 Number of the research/artictic/other outputs registered in the Web of Science or Scopus databases 11 10
VI.1.3 Number of citations corresponding to the research/artictic/other outputs 57 56
VI.1.4 Number of citations registered in the Web of Science or Scopus databases 56 55
VI.1.5 Number of invited lectures at the international, national level 1 1

VI.2. The most significant research/artistic/other outputs 5
1. MIKLÁŠOVÁ, Natália - HERICH, Peter - DAVILA-BECERRIL, Juan Carlos - BARROSO-FLORES, Joaquin - FISCHER-FODOR, Eva - VALENTOVÁ, Jindra - LEŠKOVSKÁ, Janka - KOŽÍŠEK, Jozef - TAKÁČ, Peter - MOJŽIŠ, Ján. Evaluation of antiproliferative Palladium(II) complexes of synthetic bisdemethoxycurcumin towards in vitro cytotoxicity and molecular docking on DNA sequence. In: Molecules. 2021. ISSN 1420-3049, Vol. 26, no. 14 (2021), art. no. 4369, p. [1-15]
(2021: 4.927 - IF, 171 - H-index, 5.110 - IF 5y, 0.705 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
2. TAKÁČ, Peter - KELLO, Martin - VILKOVÁ, Mária - VAŠKOVÁ, Janka - MICHALKOVÁ, Radka - MOJŽIŠOVÁ, Gabriela - MOJŽIŠ, Ján. Antiproliferative effect of acridine chalcone is mediated by induction of oxidative stress. In: Biomolecules. 2020. ISSN 2218-273X, Vol. 10, no. 2 (2020), art. no. 345, p. [1-19]
(2020: 4.879 - IF, 52 - H-index, 5.362 - IF 5y, 1.125 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q)
3. KELLO, Martin - TAKÁČ, Peter - KUBATKA, Peter - KURUC, Tomáš - PETROVÁ, Klaudia - MOJŽIŠ, Ján. Oxidative stress-induced DNA damage and apoptosis in clove buds-treated MCF-7 cells. In: Biomolecules. 2020. ISSN 2218-273X, Vol. 10, no. 1 (2020), art. no. 139, p. [1-15]
(2020: 4.879 - IF, 52 - H-index, 5.362 - IF 5y, 1.125 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q)
4. TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292(2018), s. 37-49.
(2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
5. ČIŽMÁRIKOVÁ, Martina - TAKÁČ, Peter - SPENGLER, Gabriela - KINCSES, Annamária - NOVÉ, Márta - VILKOVÁ, Mária - MOJŽIŠ, Ján. New Chalcone derivative inhibits ABCB1 in multidrug resistant T-cell lymphoma and colon adenocarcinoma cells. In: Anticancer Research. 2019. ISSN 0250-7005, Vol. 39, no. 12 (2019), p. 6499-6505.
(2019: 1.994 - IF, 117 - H-index, 1.931 - IF 5y, 0.716 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q)
5 Maximum of five most significant outputs, if the RATP form is attached to the application.

VI.3. The most significant research/artistic/other outputs over the last six years 6
1. MIKLÁŠOVÁ, Natália - HERICH, Peter - DAVILA-BECERRIL, Juan Carlos - BARROSO-FLORES, Joaquin - FISCHER-FODOR, Eva - VALENTOVÁ, Jindra - LEŠKOVSKÁ, Janka - KOŽÍŠEK, Jozef - TAKÁČ, Peter - MOJŽIŠ, Ján. Evaluation of antiproliferative Palladium(II) complexes of synthetic bisdemethoxycurcumin towards in vitro cytotoxicity and molecular docking on DNA sequence. In: Molecules. 2021. ISSN 1420-3049, Vol. 26, no. 14 (2021), art. no. 4369, p. [1-15]
(2021: 4.927 - IF, 171 - H-index, 5.110 - IF 5y, 0.705 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
2. TAKÁČ, Peter - KELLO, Martin - VILKOVÁ, Mária - VAŠKOVÁ, Janka - MICHALKOVÁ, Radka - MOJŽIŠOVÁ, Gabriela - MOJŽIŠ, Ján. Antiproliferative effect of acridine chalcone is mediated by induction of oxidative stress. In: Biomolecules. 2020. ISSN 2218-273X, Vol. 10, no. 2 (2020), art. no. 345, p. [1-19]
(2020: 4.879 - IF, 52 - H-index, 5.362 - IF 5y, 1.125 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q)
3. KELLO, Martin - TAKÁČ, Peter - KUBATKA, Peter - KURUC, Tomáš - PETROVÁ, Klaudia - MOJŽIŠ, Ján. Oxidative stress-induced DNA damage and apoptosis in clove buds-treated MCF-7 cells. In: Biomolecules. 2020. ISSN 2218-273X, Vol. 10, no. 1 (2020), art. no. 139, p. [1-15]
(2020: 4.879 - IF, 52 - H-index, 5.362 - IF 5y, 1.125 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q)
4. TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292(2018), s. 37-49.
(2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
5. ČIŽMÁRIKOVÁ, Martina - TAKÁČ, Peter - SPENGLER, Gabriela - KINCSES, Annamária - NOVÉ, Márta - VILKOVÁ, Mária - MOJŽIŠ, Ján. New Chalcone derivative inhibits ABCB1 in multidrug resistant T-cell lymphoma and colon adenocarcinoma cells. In: Anticancer Research. 2019. ISSN 0250-7005, Vol. 39, no. 12 (2019), p. 6499-6505.
(2019: 1.994 - IF, 117 - H-index, 1.931 - IF 5y, 0.716 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q)
6 Maximum of five most significant outputs over the last six years, if the RATP form is attached to the application.

VI.4. The most significant citations corresponding to the research/artistic/other outputs 7
1. TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292(2018), s. 37-49.
(2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
[1] JASIM, Hiba A. - NAHAR, Lutfun - JASIM, Mohammad A. - MOORE, Sharon A. - RITCHIE, Kenneth J. - SARKER, Satyajit D. Chalcones: Synthetic Chemistry Follows Where Nature Leads. In BIOMOLECULES, 2021, vol. 11, no. 8, pp.
2. TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292(2018), s. 37-49.
(2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
[1] KHAMTO, Nopawit - CHAICHUANG, Lada - RITHCHUMPON, Puracheth - PHUPONG, Worrapong - BHOOPONG, Phuangthip - TATEING, Suriya - POMPIMON, Wilart - SEMAKUL, Natthawat - CHOMSRI, Ni-orn - MEEPOWPAN, Puttinan. Synthesis, cytotoxicity evaluation and molecular docking studies on 2 ',4 '-dihydroxy-6 '-methoxy-3 ',5 '-dimethylchalcone derivatives. In RSC ADVANCES, 2021, vol. 11, no. 50, pp. 31433-31447.
3. TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292(2018), s. 37-49.
(2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
[1] KUMAR, Vishal - DHAWAN, Sanjeev - GIRASE, Pankaj Sanjay - AWOLADE, Paul - SHINDE, Suraj Raosaheb - KARPOORMATH, Rajshekhar - SINGH, Parvesh. Recent advances in chalcone-based anticancer heterocycles: A structural and molecular target perspective. In CURRENT MEDICINAL CHEMISTRY. ISSN 0929-8673, 2021, vol. 28, no. 33, pp. 6805-6845.
4. TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292(2018), s. 37-49.
(2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
[1] MESSEHA, Samia S. - ZARMOUH, Najla O. - SOLIMAN, Karam F. A. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer. In NUTRIENTS, 2021, vol. 13, no. 5, pp.
5. TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292(2018), s. 37-49.
(2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q)
[1] SAFWAT, Ghada M. - HASSANIN, Kamel M. A. - MOHAMMED, Eman T. - AHMED, Essam Kh. - ABDEL RHEIM, Mahmoud R. - AMEEN, Mohamed A. - ABDEL-AZIZ, Mohamed - GOUDA, Ahmed M. - PELUSO, Ilaria - ALMEER, Rafa - ABDEL-DAIM, Mohamed M. - ABDEL-WAHAB, Ahmed. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines. In OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. ISSN 1942-0900, 2021, vol. 2021, no., pp. Dostupné na: https://doi.org/10.1155/2021/4759821.
7 Maximum of five most significant citations, if the RATP form is attached to the application.

VI.5. Participation in conducting (leading) the most important research projects or art projects over the last six years 8
1. VEGA 1/0166/21 "Effect of combined exposure to neonicotinoid insecticides and azole antifungal agents on selected species of non-target organisms ", Duration: 2021 - 2024
2. VEGA 1/0753/17 "Vplyv prírodných látok na nádorové mikroprostredie", Duration: 2017 - 2020
3. VEGA 1/0018/16 "Molekulové mechanizmy antiproliferatívneho účinku chalkónov u nádorov mliečnej žľazy: in vitro štúdia", Duration: 2016 - 2019
4. Iné 2018-904 "Inovácia výučby farmakológie využitím e- learningových edukačných a testovacích materiálov v kontexte aplikácie zmiešanej edukácieInovácia výučby farmakológie využitím e- learningových edukačných a testovacích materiálov v kontexte aplikácie zmiešanej edukácie", Duration: 2018 - 2019
5. Iné 21/GSD/2016 "Chalkóny inhibujúce signálnu dráhu NF-κB ako potenciálne protinádorové liečivá ", Duration: 2016 - 2017
8 Maximum of five most significant projects, if the RATP form is attached to the application. In addition to the name and brief characteristics of the project, the type of participation is indicated (in Slovak and in English), if possible, a hyperlink to the project and its outputs and citations are stated as well.

VII. OVERVIEW OF ORGANIZATIONAL EXPERIENCE RELATED TO HIGHER EDUCATION AND RESEARCH/ARTISTIC/OTHER ACTIVITIES 9
VII.a Activity, position VII.b Name of the institution, board VII.c Duration
member of Council of the Department of Pharmacology and Toxicology University of veterinary medicine and Pharmacy in Košice 2020 up to now
member of Slovak Medical Association with membership in Pharmacological professional association 2018 up to now
9 E.g. academic positions, memberships in editorial boards and in scientific and professional societies.

VIII. OVERVIEW OF INTERNATIONAL MOBILITIES AND VISITS ORIENTED ON EDUCATION AND RESEARCH/ARTISTIC/ OTHER ACTIVITIES IN THE GIVEN FIELD OF STUDY
VIII.a Name of the institution VIII.b Address of the institution VIII.c Duration (indicate the duration of stay) VIII.d Mobility scheme, employment contract, other (describe)

IX. OTHER RELEVANT FACTS 10
IX.a If relevant, other activities related to higher education or research/artictic/other activities are mentioned
10 Maximum of 1800 characters, if the RATP form is attached to the application.
Skip to content